B
86.05
0.49 (0.57%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Bullish | Bullish |
| Diagnostics & Research (Global) | Bullish | Bullish | |
| Stock | BillionToOne, Inc. | - | - |
AIStockmoo Score
1.5
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 1.50 |
|
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 160.00 (BTIG, 85.94%) | Buy |
| Median | 145.00 (68.51%) | |
| Low | 110.00 (Wells Fargo, 27.83%) | Hold |
| Average | 137.83 (60.17%) | |
| Total | 4 Buy, 2 Hold | |
| Avg. Price @ Call | 109.93 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BTIG | 10 Dec 2025 | 160.00 (85.94%) | Buy | 103.70 |
| 01 Dec 2025 | 160.00 (85.94%) | Buy | 113.04 | |
| JP Morgan | 10 Dec 2025 | 145.00 (68.51%) | Buy | 103.70 |
| 01 Dec 2025 | 150.00 (74.32%) | Buy | 113.04 | |
| Jefferies | 01 Dec 2025 | 117.00 (35.97%) | Hold | 113.04 |
| Piper Sandler | 01 Dec 2025 | 150.00 (74.32%) | Buy | 113.04 |
| Stifel | 01 Dec 2025 | 145.00 (68.51%) | Buy | 113.04 |
| Wells Fargo | 01 Dec 2025 | 110.00 (27.83%) | Hold | 113.04 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 15 Jan 2026 | Announcement | BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare |
| 12 Jan 2026 | Announcement | BillionToOne Provides Guidance for 2026 |
| 06 Jan 2026 | Announcement | BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East |
| 23 Dec 2025 | Announcement | BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference |
| 09 Dec 2025 | Announcement | BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair |
| 09 Dec 2025 | Announcement | BillionToOne Reports Third Quarter 2025 Results |
| 02 Dec 2025 | Announcement | BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |